Biogen · 20 hours ago
Head of Immunobiology Therapeutic Innovation
San Francisco, CA
Full-time
Onsite
Director/Executive
$250K/yr - $344K/yr
15+ years expBiogen is seeking an accomplished scientific leader to serve as Head of Immunobiology Therapeutic Innovation within the Immunology Research Unit. This role will define and execute Biogen’s strategy for emerging therapeutic modalities in immunology, driving innovation from early discovery through early development.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Define and execute a forward-looking strategy for modality innovation across autoimmune and inflammatory indications
Drive programs from target validation through IND-enabling studies, ensuring robust mechanistic and disease-relevant data packages
Partner with translational medicine, clinical development, and external collaborators to accelerate portfolio progression
Serve as a scientific lead for evaluating external opportunities in emerging modalities and immunology platforms
Collaborate with Biogen’s Business Development, External Innovation, and Ventures teams to identify, assess, and integrate partnerships, licensing, and investment opportunities
Represent Biogen in external scientific forums, consortia, and strategic collaborations
Build and lead a high-performing team focused on modality innovation and translational immunology
Foster a culture of scientific excellence, collaboration, and diversity
Mentor and develop talent across levels
Act as a subject matter expert in immunobiology and emerging therapeutic modalities, including: Next-generation immune cell engagers, Novel bispecific antibodies, Protein homeostasis platforms, Peptide macrocycles, Antibody-drug conjugates (ADCs)
Stay ahead of scientific trends and competitive landscape to inform strategic decisions
Contribute to publications, presentations, and thought leadership in the field
Qualification
Required
Ph.D. in Immunology or related field with 15+ years of industry or academic experience
Proven track record of leading discovery and translational programs from early discovery into clinical development
Strong understanding of immunobiology and emerging therapeutic modalities
Experience managing scientific teams and driving portfolio strategy
Demonstrated ability to lead external collaborations and diligence efforts
Preferred
Experience with both large and small molecule drug discovery and development
Familiarity with autoimmune disease models and application to human disease biology
Prior involvement in business development, external innovation, or venture activities
Benefits
Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Founded in 1978Cambridge, Massachusetts, USA
5001-10000 employees
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Robin C. Kramer
Executive Vice President, Chief Financial Officer
Priya Singhal
Executive Vice President, Head of Development
Recent News
2026-01-16
2026-01-16
Company data provided by crunchbase